HomeACHL • NASDAQ
add
Achilles Therapeutics PLC
Previous close
$0.94
Day range
$0.90 - $0.96
Year range
$0.74 - $1.76
Market cap
38.20M USD
Avg Volume
217.66K
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 14.30M | -22.93% |
Net income | -12.27M | 29.89% |
Net profit margin | — | — |
Earnings per share | -0.30 | 31.82% |
EBITDA | -13.12M | 24.79% |
Effective tax rate | 0.19% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 112.32M | -29.12% |
Total assets | 145.74M | -29.81% |
Total liabilities | 15.39M | -31.48% |
Total equity | 130.35M | — |
Shares outstanding | 41.09M | — |
Price to book | 0.30 | — |
Return on assets | -23.27% | — |
Return on capital | -25.39% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -12.27M | 29.89% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2016
Website
Employees
210